FGF-23 Levels in Patients with AKI and Risk of Adverse Outcomes
Clinical Journal of the American Society of Nephrology, 08/08/2012
Leaf DE et al. – Among patients with AKI, fibroblast growth factor 23 levels are elevated and associated with greater risk of death or need for renal replacement therapy.



